phenyl acetate has been researched along with Hepatitis, Viral, Human in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andre, P; Asner, SA; Buclin, T; Decosterd, LA; Gengler, C; Jaton-Ogay, K; Mercier, T; Meylan, P; Murray, K; Natterer, J; Opota, O; Pérez Marín, M; Perez, MH; Rizzi, M | 1 |
| ALLEN, JG; BENHAM, RS; DAWSON, D; HAVENS, I; HUMPHREYS, EM; SAYMAN, WA | 1 |
2 other study(ies) available for phenyl acetate and Hepatitis, Viral, Human
| Article | Year |
|---|---|
Compassionate Use of Letermovir in a 2-Year-Old Immunocompromised Child With Resistant Cytomegalovirus Disease.
Topics: Acetates; Antiviral Agents; Child, Preschool; Compassionate Use Trials; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Dose-Response Relationship, Drug; Drug Monitoring; Extracorporeal Membrane Oxygenation; Fatal Outcome; Female; Ganciclovir; Hepatitis, Viral, Human; Humans; Immunocompromised Host; Opportunistic Infections; Pneumonia, Viral; Polymerase Chain Reaction; Quinazolines; Treatment Failure; Viral Load | 2020 |
Blood transfusions and serum hepatitis: use of monochloroacetate as an antibacterial agent in plasma.
Topics: Acetates; Anti-Bacterial Agents; Blood Transfusion; Hepatitis B; Hepatitis, Viral, Human; Jaundice | 1959 |